Cells are constantly on the move, whether in a developing embryo or metastatic cancer. But how do cells adapt to the new ...

Bile reflux gastritis (BRG) is a gastro-intestinal condition especially characterized by the reflux of bile into the stomach, further leading to mucosal inflammation along with various other clinical ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...

Astria advances innovative therapies for hereditary angioedema and atopic dermatitis. Strong cash position supports pivotal ...

Shahram Sharif, CEO of Liva Healthcare, said: "Today's news marks a step-change in Liva's ambitions ... health technology platform with human-led therapeutic intervention programmes that deliver ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

The Novoheart platform has facilitated and accelerated the development of Sardocor's lead therapeutic candidates ... timelines for its gene and cell therapy pipeline. Sardocor has received ...

This fear of change can lead to doubts about whether therapy is worth the effort or whether it might inadvertently make things worse. To help combat your fears of starting relationship therapy ...

The company's lead therapeutic candidate ... and other important factors, any of which could cause TransCode's actual results to differ from those contained in or implied by the forward-looking ...

With accomplishments spanning more than two decades in occupational therapy education and clinical ... “I am honored to join USAHS and lead efforts that will not only strengthen our programs ...